Researchers have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumour microenvironment, sparing healthy cells.

Jaipur: Crime branch of Jaipur police Thursday busted an interstate fake currency racket, arresting three persons and recovering counterfeit notes with a face value of Rs 6.51 lakh during an operation ...

Thomas Anderson – otherwise known as Neo – is walking up a flight of stairs when he sees a black cat shake itself and walk past a doorway. Then the moment seems to replay before his eyes. Just a touch ...

Chicago’s South Side residents now have access to a new sickle-cell treatment clinic at Roseland Community Hospital. On Monday, Roseland held a ribbon-cutting ceremony introducing Dr. Mahoud Mahafzah ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Creating a virtual brain may sound like a science-fiction nightmare, but for neuroscientists in Japan and at Seattle’s Allen Institute, it’s a big step toward a long-held dream. They say their ...

The idea that we’re living inside a simulation, as popularized by “The Matrix” franchise, has piqued the interest of scientists for decades. In 2003, philosopher Nick Bostrom proposed in a highly ...

The true nature of our universe as been an open debate for millennia, and recently, scientists and philosophers have pondered whether it might be a hyper-realistic simulation perpetuated by some super ...

If such a simulation were possible, the simulated universe could itself give rise to life, which in turn might create its own simulation. This recursive possibility makes it seem highly unlikely that ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...